I don't think Opex of $1,500/t is reasonable.
Here's CXO as an example:
- First spodumene produced on 27 February 2023, produced 3,589t in the March quarter; 14,685t in the June 2023 quarter with C1 cost of A$902/t.
Quarterly spodumene production of 14,685t (FY23: 18,274t) at a C1 unit cost of $902/t (FY23: $1,230/t).
CXO did have excess rainfall, very low recovery (49%), and a much lower annual capacity.
As CXO's guideline of 80-90ktpa spodumene, LTR's capacity is 6-7 times of CXO.
Economic of scale prevails, imo.
Ann: Investor Presentation - BMO Conference, page-116
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.0¢ |
Change
-0.045(6.29%) |
Mkt cap ! $1.624B | |||
| Open | High | Low | Value | Volume |
| 70.0¢ | 71.0¢ | 67.0¢ | $10.52M | 15.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 385809 | 66.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 67.5¢ | 116000 | 4 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| LTR (ASX) Chart |